2 completed, 2 terminated. 4 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Terminated 2 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow MBP-8298: new trials by email Literature Review of MBP-8298 trials Research Report on MBP-8298
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis MBP8298 - Multiple Sclerosis, Secondary Progressive | Phase 3 | Terminated | BioMS Technology Corp. | 510 | 2007-06-01 | 2009-08-13 |
| A Study for Patients With Multiple Sclerosis dirucotide - Secondary Progressive Multiple Sclerosis | Phase 2 / Phase 3 | Terminated | Eli Lilly and Company | 546 | 2007-02-01 | 2010-09-09 |
| A Study for Patients With Relapsing Remitting Multiple Sclerosis dirucotide, placebo - Relapsing Remitting Multiple Sclerosis | Phase 2 / Phase 3 | Completed | Eli Lilly and Company | 218 | 2006-11-01 | 2010-09-09 |
| A Study for Patients With Secondary Progressive Multiple Sclerosis dirucotide, Placebo - Secondary Progressive Multiple Sclerosis | Phase 2 / Phase 3 | Completed | Eli Lilly and Company | 596 | 2004-12-01 | 2010-06-02 |
Multiple Sclerosis, Chronic Progressive (3) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Eli Lilly and Company (3) · BioMS Technology Corp. (1)
Canada (2) · Denmark (2) · Estonia (2) · Finland (2) · Germany (2) · Latvia (2) · Netherlands (2) · Spain (2) · Sweden (2) · United Kingdom (2) · Bulgaria (1) · Poland (1) · Russia (1) · Serbia (1) · Slovakia (1)